Effects of Forskolin on Placental Vascular Resistance in Rabbits 1 2

Abstract

Abstract

Forskolin is a direct stimulant of adenylate cyclase and increases cAMP production. It also acts as a vasodilator. To study the effect of forskolin infusion on rabbit maternal vascular resistance, we instrumented 11 pregnant rabbits with catheters in the left ventricle, jugular vein, and left and right femoral arteries. After a 2-day recovery period, one of two protocols was performed. In the control period of the first protocol (N = 6), 50% ethanol in saline was infused at 0.103 ml · min^-1 for 5-min. Forskolin (10^-3 M) in 50% ethanol was then infused for 5 min at 0.103 ml · min^-1. After each infusion period, regional blood flows were measured by microsphere injection. Data are expressed as means ± SEM. Blood pressure decreased from 81 ± 3 to 79 ± 3 mm Hg, (P < 0.05, N = 10) during forskolin infusion. Total placental resistance fell from 180.3 ± 10.7 to 133.8 ± 12.0 mm Hg ± min ± ml^-1 per gram, P < 0.05. Cerebral, coronary, and renal vascular resistance fell significantly. During the second protocol (N = 5), angiotensin II (0.05 μg ± min^-1) was infused for 5 min followed by the addition of forskolin (10^-3 M at 0.103 ml ± min^-1) to the infusate. Regional blood flows, vascular resistances and blood pressures were determined. Blood pressure fell from 99 ± 6 to 92 ± 7 mm Hg (P < 0.05) when forskolin was added to the infusate. Placental resistance fell from 202.5 ± 21.6 to 158.0 ± 29.0 mm Hg · min · ml^-1 per gram (P < 0.05). While cerebral vascular resistance did not change, renal and coronary resistances fell in response to forskolin. This study demonstrates that forskolin is able to dilate rabbit placental vessels alone and in the presence of the vasoconstrictive agent angiotensin II.